Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury

October 25, 2021 updated by: Jeremy Myers, University of Utah

The Outcomes of Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury

Pelvic fracture urethral injuries (PFUI) occur in up to 10% of pelvic fractures. It remains controversial whether initial urethral realignment after PFUI decreases rates of urethral obstruction and the need for subsequent urethral procedures.

The retrospective record review should determine the utility of acute urethral realignment after PFUI.

Study Overview

Detailed Description

A retrospective chart review to compare outcomes between urethral realignment (group 1) and suprapubic tube (SPT) placement (group 2). The comparison will be between two routinely practiced management approaches of urethral injury after pelvic fracture.

Prior studies demonstrate urethral realignment is associated with a 15% to 50% reduction in urethral obstruction, however, it has also been associated with higher rates of incontinence and erectile dysfunction. Our hypothesis is that early realignment of traumatic urethral injuries after pelvic fracture lowers the incidence of complications like urethral strictures and subsequent need for surgeries.

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Utah
      • Salt Lake City, Utah, United States, 84132
        • University of Utah

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Men experiencing a traumatic pelvic fracture urethral injury where there is a major urethral disruption that prevents passage of a catheter or a retrograde cystoscope.

Description

Inclusion Criteria:

Men > 18 years old Blunt force trauma Presence of pelvic fracture Urethral injury Inability to pass a Foley catheter retrograde through the injury into the bladder

Exclusion Criteria:

Straddle type urethral injuries without a pelvic fracture Passage of a catheter successfully in a retrograde fashion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Suprapubic tube placement
Standard of care management for men with complete urethral injuries where a Foley catheter fails to be placed will have a suprapubic tube placed to manage the acute urethral injury. This is a standard of care approach and a retrospective review will be done on the patient record to determine outcomes.
Urethral realignment
Standard of care management for men with complete urethral injuries where a Foley catheter fails to be placed will undergo urethral realignment with a combined antegrade / retrograde approach within 7 days of injury. This is a standard of care approach and a retrospective review will be done on the patient record to determine outcomes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urethral obstruction
Time Frame: Through study completion, an average of 1 year
Rates of urethral obstruction identified by urethrogram or cystoscopy
Through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment rate for urethral obstruction
Time Frame: Through study completion, an average of 1 year
The rate of interventions for urethral obstruction after injury
Through study completion, an average of 1 year
Urethroplasty complexity - gap length during urethroplasty
Time Frame: Through study completion, an average of 1 year
The gap between the 2 severed ends of the urethra
Through study completion, an average of 1 year
Urethroplasty complexity - bulbar mobilization length during urethroplasty
Time Frame: Through study completion, an average of 1 year
The length of bulbar mobilization
Through study completion, an average of 1 year
Urethroplasty complexity - corporal splitting during urethroplasty
Time Frame: Through study completion, an average of 1 year
The need to split the 2 corporal bodies
Through study completion, an average of 1 year
Urethroplasty complexity - total obstruction of the urethra during urethroplasty
Time Frame: Through study completion, an average of 1 year
Finding the urethra was completely obstructed
Through study completion, an average of 1 year
Urethroplasty complexity - urethral diverticulum discovered during urethroplasty
Time Frame: Through study completion, an average of 1 year
Finding a urethral diverticulum
Through study completion, an average of 1 year
Urethroplasty complexity - urethral fistula present
Time Frame: Through study completion, an average of 1 year
Finding a urethral fistula
Through study completion, an average of 1 year
Urethroplasty complexity - inferior pubectomy during urethroplasty
Time Frame: Through study completion, an average of 1 year
The need to remove the inferior portion of the symphysis pubis
Through study completion, an average of 1 year
Urethroplasty complexity - total pubectomy during urethroplasty
Time Frame: Through study completion, an average of 1 year
The need to remove the complete symphysis pubis
Through study completion, an average of 1 year
Erectile function- SHIM score
Time Frame: Through study completion, an average of 1 year
Erectile function measured by the Sexual Health Inventory for Men (SHIM)
Through study completion, an average of 1 year
Erectile function - medical treatment rates
Time Frame: Through study completion, an average of 1 year
Measured by the need for pharmacologic treatment of erectile dysfunction
Through study completion, an average of 1 year
Erectile function - surgical treatment rates
Time Frame: Through study completion, an average of 1 year
Rates of surgical treatment of erectile dysfunction
Through study completion, an average of 1 year
Incontinence
Time Frame: Through study completion, an average of 1 year
Rates of surgical treatment of incontinence
Through study completion, an average of 1 year
Post-injury complications
Time Frame: 3 month period post acute urethral injury
Calvien-Dindo grading
3 month period post acute urethral injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeremy Myers, MD, University of Utah

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

August 31, 2021

Study Completion (Actual)

August 31, 2021

Study Registration Dates

First Submitted

June 16, 2017

First Submitted That Met QC Criteria

June 19, 2017

First Posted (Actual)

June 22, 2017

Study Record Updates

Last Update Posted (Actual)

October 27, 2021

Last Update Submitted That Met QC Criteria

October 25, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma

3
Subscribe